Global Contrast Media Injectors Market to reach USD 2.1 billion by 2027

Global Contrast Media Injectors Market Size study, by Type (Single Head Injectors, Dual Head Injectors, Syringeless Injectors), by Product (Injector Systems, Consumables), by Application (Radiology, Interventional Cardiology, Interventional Radiology), by End-Use (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers (ASCs)) and Regional Forecasts 2020-2027
Product Code:  HALMDAE_11607441
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Contrast Media Injectors Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Contrast Media Injectors Market, by Type, 2018-2027 (USD Billion)
1.2.3.	Contrast Media Injectors Market, by Product, 2018-2027 (USD Billion)
1.2.4.	Contrast Media Injectors Market, by Application, 2018-2027 (USD Billion)
1.2.5.	Contrast Media Injectors Market, by End-Use, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Contrast Media Injectors Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Contrast Media Injectors Market Dynamics	
3.1.	Contrast Media Injectors Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Contrast Media Injectors Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Contrast Media Injectors Market, by Type 
5.1.	Market Snapshot 
5.2.	Global Contrast Media Injectors Market by Type, Performance - Potential Analysis
5.3.	Global Contrast Media Injectors Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4.	Contrast Media Injectors Market, Sub Segment Analysis
5.4.1.	Single Head Injectors
5.4.2.	Dual Head Injectors
5.4.3.	Syringeless Injectors
Chapter 6.	Global Contrast Media Injectors Market, by Product
6.1.	Market Snapshot 
6.2.	Global Contrast Media Injectors Market by Product, Performance - Potential Analysis
6.3.	Global Contrast Media Injectors Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
6.4.	Contrast Media Injectors Market, Sub Segment Analysis
6.4.1.	Injector Systems
6.4.2.	Consumables 
Chapter 7.	Global Contrast Media Injectors Market, by Application          
7.1.	Market Snapshot 
7.2.	Global Contrast Media Injectors Market by Application, Performance - Potential Analysis
7.3.	Global Contrast Media Injectors Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4.	Contrast Media Injectors Market, Sub Segment Analysis
7.4.1.	Radiology
7.4.2.	Interventional Cardiology
7.4.3.	Interventional Radiology
Chapter 8.	Global Contrast Media Injectors Market, by End-Use
8.1.	Market Snapshot 
8.2.	Global Contrast Media Injectors Market by End-Use - Potential Analysis
8.3.	Global Contrast Media Injectors Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
8.4.	Contrast Media Injectors Market, Sub Segment Analysis
8.4.1.	Hospitals
8.4.2.	Diagnostic Centers
8.4.3.	Ambulatory Surgery Centers (ASCs)
Chapter 9.	Global Contrast Media Injectors Market, Regional Analysis
9.1.	Contrast Media Injectors Market, Regional Market Snapshot 
9.2.	North America Contrast Media Injectors Market 
9.2.1.	U.S. Contrast Media Injectors Market
9.2.1.1.	Type breakdown estimates & forecasts, 2017-2027
9.2.1.2.	Product breakdown estimates & forecasts, 2017-2027
9.2.1.3.	Application breakdown estimates & forecasts, 2017-2027
9.2.1.4.	End-Use breakdown estimates & forecasts, 2017-2027
9.2.2.	Canada Contrast Media Injectors Market
9.3.	Europe Contrast Media Injectors Market Snapshot
9.3.1.	U.K. Contrast Media Injectors Market 
9.3.2.	Germany Contrast Media Injectors Market
9.3.3.	France Contrast Media Injectors Market
9.3.4.	Spain Contrast Media Injectors Market
9.3.5.	Italy Contrast Media Injectors Market
9.3.6.	Rest of Europe Contrast Media Injectors Market
9.4.	Asia-Pacific Contrast Media Injectors Market Snapshot
9.4.1.	China Contrast Media Injectors Market 
9.4.2.	India Contrast Media Injectors Market 
9.4.3.	Japan Contrast Media Injectors Market
9.4.4.	Australia Contrast Media Injectors Market
9.4.5.	South Korea Contrast Media Injectors Market
9.4.6.	Rest of Asia Pacific Contrast Media Injectors Market
9.5.	Latin America Contrast Media Injectors Market Snapshot
9.5.1.	Brazil Contrast Media Injectors Market
9.5.2.	Mexico Contrast Media Injectors Market
9.6.	Rest of The World Contrast Media Injectors Market
Chapter 10.	Competitive Intelligence
10.1.	Top Market Strategies
10.2.	Company Profiles
10.2.1.	Bracco Group
10.2.1.1.	Key Information
10.2.1.2.	Overview
10.2.1.3.	Financial (Subject to Data Availability)
10.2.1.4.	Product Summary
10.2.1.5.	Recent Developments
10.2.2.	Bayer HealthCare LLC
10.2.3.	Guerbet Group
10.2.4.	Medtron AG
10.2.5.	GE Healthcare
10.2.6.	ulrich GmbH & Company KG
10.2.7.	Nemoto Kyorindo Co., Ltd.
10.2.8.	Sino Medical-Device Technology Co., Ltd.
10.2.9.	APOLLO RT Co. Ltd.
10.2.10.	VIVID Imaging
Chapter 11.	Research Process
11.1.	Research Process
11.1.1.	Data Mining
11.1.2.	Analysis
11.1.3.	Market Estimation
11.1.4.	Validation
11.1.5.	Publishing
11.2.	Research Attributes
11.3.	Research Assumption

Global Contrast Media Injectors Market is valued approximately at USD 1.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2020-2027. Contrast media injectors (CMI) has been developed and employed for injecting contrast agents into the human’s body, to enhance the range of tissues for conducting medical imaging procedures. Presently, several advancements have been performed with contrast media injector technology, such as reduce costs by cutting down contrast waste and automated data assortment for the dose a patient takes. The automated injector system not only accurately manages the amount of contrast waste; but also offers personalized doses for patients by utilizing information collected from a picture archiving and communication system (PACS) or electronic medical record (EMR). Contrast dose recording software further provides new potential for radiology departments that streamline the usage of contrast media, which may drive the market growth during the forecast period. Furthermore, rising prevalence of chronic diseases such as cancer and cardiovascular disease, increasing regulatory approvals of contrast agents, and rising investment and government funding in the development of contrast media injectors are the few factors responsible for the CAGR of the market during the forecast period. According to the International Agency for Research on Cancer (IARC), around 18.1 million new cancer cases and 9.6 million cancer deaths were reported throughout the world in 2018. Also, the global prevalence of cancer is projected to grow to around 27.5 million new cancer cases and nearly 16.3 million cancer deaths by the year 2040. This, in turn, is likely to strengthen the demand for contrast media injector, globally. However, the high development cost of contrast media injectors & accessories and unfavorable outcomes of contrast agents are the few factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Contrast Media Injectors market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing demand for minimally invasive procedures, along with the wide presence of market players in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and cardiovascular diseases, coupled with improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the cancer vaccine market in the Asia-Pacific region.

Major market player included in this report are:
Bracco Group
Bayer HealthCare LLC
Guerbet Group
Medtron AG
GE Healthcare
ulrich GmbH & Company KG
Nemoto Kyorindo Co., Ltd.
Sino Medical-Device Technology Co., Ltd.
APOLLO RT Co. Ltd.
VIVID Imaging

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Single Head Injectors
Dual Head Injectors
Syringeless Injectors

By Product:
Injector Systems
Consumables

By Application:
Radiology
Interventional Cardiology
Interventional Radiology

By End-Use:
Hospitals
Diagnostic Centers
Ambulatory Surgery Centers (ASCs)

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Contrast Media Injectors Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…